| Pathway ID | hsa05166 |
| Pathway Term | HTLV-I infection |
| Pathway Source | KEGG |
| Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
|---|---|---|---|---|
ADCY3 | adenylate cyclase 3 |
109 | O60266 | chr2: 24,819,169-24,919,839 |
ADCY7 | adenylate cyclase 7 |
113 | P51828 | chr16: 50,246,137-50,318,135 |
ADCY9 | adenylate cyclase 9 |
115 | O60503 | chr16: 3,953,387-4,116,185 |
AKT1 | v-akt murine thymoma viral oncogene homolog 1 |
207 | P31749 | chr14: 104,769,349-104,795,751 |
AKT2 | v-akt murine thymoma viral oncogene homolog 2 |
208 | P31751 | chr19: 40,230,317-40,285,536 |
AKT3 | v-akt murine thymoma viral oncogene homolog 3 |
10000 | Q9Y243 | chr1: 243,488,233-243,851,079 |
ANAPC1 | anaphase promoting complex subunit 1 |
64682 | Q9H1A4 | chr2: 111,766,271-111,884,690 |
ANAPC10 | anaphase promoting complex subunit 10 |
10393 | Q9UM13 | chr4: 144,831,908-145,098,541 |
ANAPC4 | anaphase promoting complex subunit 4 |
29945 | Q9UJX5 | chr4: 25,377,213-25,418,498 |
ANAPC5 | anaphase promoting complex subunit 5 |
51433 | Q9UJX4 | chr12: 121,308,245-121,399,896 |
APC | adenomatous polyposis coli |
324 | P25054 | chr5: 112,707,498-112,846,239 |
ATF1 | activating transcription factor 1 |
466 | P18846 | chr12: 50,763,710-50,821,122 |
ATF3 | activating transcription factor 3 |
467 | P18847 | chr1: 212,565,334-212,620,777 |
ATF4 | activating transcription factor 4 |
468 | P18848 | chr22: 39,519,695-39,522,685 |
BAX | BCL2-associated X protein |
581 | Q07812 | chr19: 48,954,815-48,961,798 |
BUB1B | BUB1B, mitotic checkpoint serine/threonine kinase |
701 | O60566 | chr15: 40,161,023-40,221,136 |
BUB3 | BUB3 mitotic checkpoint protein |
9184 | O43684 | chr10: 123,154,277-123,170,467 |
CALR | calreticulin |
811 | P27797 | chr19: 12,938,578-12,944,489 |
CANX | calnexin |
821 | P27824 | chr5: 179,678,628-179,730,925 |
CCNB2 | cyclin B2 |
9133 | O95067 | chr15: 59,105,078-59,125,045 |
CCND2 | cyclin D2 |
894 | P30279 | chr12: 4,273,772-4,305,350 |
CCND3 | cyclin D3 |
896 | P30281 | chr6: 41,934,933-42,050,357 |
CDC20 | cell division cycle 20 |
991 | Q12834 | chr1: 43,358,955-43,363,203 |
CDC23 | cell division cycle 23 |
8697 | Q9UJX2 | chr5: 138,187,648-138,213,343 |
CDC27 | cell division cycle 27 |
996 | P30260 | chr17: 47,117,703-47,189,422 |
CDK4 | cyclin-dependent kinase 4 |
1019 | P11802 | chr12: 57,747,727-57,756,013 |
CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
1026 | P38936 | chr6: 36,676,460-36,687,339 |
CDKN2B | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
1030 | P42772 | chr9: 22,002,903-22,009,363 |
CDKN2C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
1031 | P42773 | chr1: 50,960,745-50,974,633 |
CHEK1 | checkpoint kinase 1 |
1111 | O14757 | chr11: 125,625,136-125,676,255 |
CREB1 | cAMP responsive element binding protein 1 |
1385 | P16220 | chr2: 207,529,737-207,603,431 |
CREBBP | CREB binding protein |
1387 | Q92793 | chr16: 3,725,054-3,880,726 |
CREM | cAMP responsive element modulator |
1390 | Q03060 | chr10: 35,126,791-35,212,958 |
CRTC3 | CREB regulated transcription coactivator 3 |
64784 | Q6UUV7 | chr15: 90,529,925-90,645,345 |
CTNNB1 | catenin beta 1 |
1499 | P35222 | chr3: 41,194,837-41,260,096 |
DLG1 | discs, large homolog 1 (Drosophila) |
1739 | Q12959 | chr3: 197,042,560-197,299,300 |
E2F1 | E2F transcription factor 1 |
1869 | Q01094 | chr20: 33,675,683-33,686,404 |
E2F2 | E2F transcription factor 2 |
1870 | Q14209 | chr1: 23,506,430-23,531,220 |
EGR1 | early growth response 1 |
1958 | P18146 | chr5: 138,465,490-138,469,315 |
EGR2 | early growth response 2 |
1959 | P11161 | chr10: 62,811,996-62,919,900 |
ELK1 | ELK1, member of ETS oncogene family |
2002 | P19419 | chrX: 47,635,521-47,650,604 |
EP300 | E1A binding protein p300 |
2033 | Q09472 | chr22: 41,091,786-41,180,079 |
ETS1 | v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
2113 | P14921 | chr11: 128,458,761-128,587,558 |
ETS2 | v-ets avian erythroblastosis virus E26 oncogene homolog 2 |
2114 | P15036 | chr21: 38,805,307-38,824,955 |
FDPS | farnesyl diphosphate synthase |
2224 | P14324 | chr1: 155,308,748-155,320,666 |
FOS | FBJ murine osteosarcoma viral oncogene homolog |
2353 | P01100 | chr14: 75,278,774-75,282,230 |
FOSL1 | FOS-like antigen 1 |
8061 | P15407 | chr11: 65,892,049-65,900,573 |
FZD4 | frizzled class receptor 4 |
8322 | Q9ULV1 | chr11: 86,945,679-86,955,391 |
FZD6 | frizzled class receptor 6 |
8323 | O60353 | chr8: 103,298,433-103,332,866 |
FZD7 | frizzled class receptor 7 |
8324 | O75084 | chr2: 202,034,587-202,038,445 |
FZD8 | frizzled class receptor 8 |
8325 | Q9H461 | chr10: 35,638,249-35,642,278 |
GPS2 | G protein pathway suppressor 2 |
2874 | Q13227 | chr17: 7,311,324-7,315,564 |
GSK3B | glycogen synthase kinase 3 beta |
2932 | P49841 | chr3: 119,821,323-120,094,417 |
HLA-A | major histocompatibility complex, class I, A |
3105 | P30443 | chr6: 29,941,260-29,945,884 |
HLA-B | major histocompatibility complex, class I, B |
3106 | P01889 | chr6: 31,269,491-31,357,188 |
HLA-C | major histocompatibility complex, class I, C |
3107 | P30499 | chr6: 31,268,749-31,272,130 |
HLA-DMA | major histocompatibility complex, class II, DM alpha |
3108 | P28067 | chr6: 32,948,613-32,969,094 |
HLA-DMB | major histocompatibility complex, class II, DM beta |
3109 | P28068 | chr6: 32,934,629-32,941,070 |
HLA-DOB | major histocompatibility complex, class II, DO beta |
3112 | P13765 | chr6: 32,812,763-32,817,048 |
HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 |
3113 | P20036 | chr6: 33,064,569-33,080,775 |
HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 |
3117 | P01909 | chr6: 32,628,179-32,647,062 |
HLA-DQA2 | major histocompatibility complex, class II, DQ alpha 2 |
3118 | P01906 | chr6: 32,741,342-32,747,215 |
HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 |
3119 | P01920 | chr6: 32,659,467-32,668,383 |
HLA-DRA | major histocompatibility complex, class II, DR alpha |
3122 | P01903 | chr6: 32,439,842-32,445,046 |
HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 |
3123 | P04229 | chr6: 32,578,769-32,589,848 |
HLA-DRB3 | major histocompatibility complex, class II, DR beta 3 |
3125 | P79483 | chr6: 32,444,128-32,457,245 |
HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 |
3126 | P13762 | chr6: 32,542,598-32,557,561 |
HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 |
3127 | Q30154 | chr6: 32,517,343-32,530,287 |
HLA-E | major histocompatibility complex, class I, E |
3133 | P13747 | chr6: 30,489,467-30,494,205 |
HLA-F | major histocompatibility complex, class I, F |
3134 | P30511 | chr6: 29,722,775-29,738,528 |
HLA-G | major histocompatibility complex, class I, G |
3135 | P17693 | chr6: 29,826,967-29,831,125 |
ICAM1 | intercellular adhesion molecule 1 |
3383 | P05362 | chr19: 10,270,835-10,286,615 |
IL1R1 | interleukin 1 receptor, type I |
3554 | P14778 | chr2: 102,064,544-102,179,874 |
IL1R2 | interleukin 1 receptor, type II |
7850 | P27930 | chr2: 101,991,844-102,028,544 |
IL6 | interleukin 6 |
3569 | P05231 | chr7: 22,725,884-22,732,002 |
ITGB2 | integrin subunit beta 2 |
3689 | P05107 | chr21: 44,885,953-44,931,989 |
JAK1 | Janus kinase 1 |
3716 | P23458 | chr1: 64,833,229-64,966,504 |
JAK3 | Janus kinase 3 |
3718 | P52333 | chr19: 17,824,780-17,848,071 |
JUN | jun proto-oncogene |
3725 | P05412 | chr1: 58,780,788-58,784,327 |
KAT2B | K(lysine) acetyltransferase 2B |
8850 | Q92831 | chr3: 20,040,023-20,154,404 |
KRAS | Kirsten rat sarcoma viral oncogene homolog |
3845 | P01116 | chr12: 25,204,789-25,250,936 |
LTBR | lymphotoxin beta receptor |
4055 | P36941 | chr12: 6,375,045-6,391,571 |
MAD2L1 | MAD2 mitotic arrest deficient-like 1 (yeast) |
4085 | Q13257 | chr4: 120,055,608-120,067,074 |
MAPK8 | mitogen-activated protein kinase 8 |
5599 | P45983 | chr10: 48,306,639-48,439,360 |
MYBL1 | v-myb avian myeloblastosis viral oncogene homolog-like 1 |
4603 | P10243 | chr8: 66,562,175-66,614,247 |
MYBL2 | v-myb avian myeloblastosis viral oncogene homolog-like 2 |
4605 | P10244 | chr20: 43,667,019-43,716,496 |
MYC | v-myc avian myelocytomatosis viral oncogene homolog |
4609 | P01106 | chr8: 127,735,434-127,741,434 |
NFATC1 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
4772 | O95644 | chr18: 79,395,856-79,529,325 |
NFATC2 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
4773 | Q13469 | chr20: 51,386,957-51,562,831 |
NFATC4 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
4776 | Q14934 | chr14: 24,365,673-24,379,604 |
NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
4790 | P19838 | chr4: 102,501,329-102,617,302 |
NFYB | nuclear transcription factor Y subunit beta |
4801 | P25208 | chr12: 104,117,077-104,138,289 |
NRAS | neuroblastoma RAS viral (v-ras) oncogene homolog |
4893 | P01111 | chr1: 114,704,469-114,716,894 |
NRP1 | neuropilin 1 |
8829 | O14786 | chr10: 33,177,492-33,336,262 |
PCNA | proliferating cell nuclear antigen |
5111 | P12004 | chr20: 5,114,953-5,126,626 |
PDGFA | platelet-derived growth factor alpha polypeptide |
5154 | P04085 | chr7: 497,258-520,296 |
PDGFB | platelet-derived growth factor beta polypeptide |
5155 | P01127 | chr22: 39,223,359-39,244,751 |
PDGFRA | platelet-derived growth factor receptor, alpha polypeptide |
5156 | P16234 | chr4: 54,229,097-54,298,247 |
PDGFRB | platelet-derived growth factor receptor, beta polypeptide |
5159 | P09619 | chr5: 150,113,837-150,155,872 |
PIK3CA | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
5290 | P42336 | chr3: 179,148,114-179,240,093 |
PIK3CB | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
5291 | P42338 | chr3: 138,652,699-138,834,938 |
PIK3CD | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
5293 | O00329 | chr1: 9,651,732-9,729,114 |
PIK3R1 | phosphoinositide-3-kinase regulatory subunit 1 |
5295 | P27986 | chr5: 68,215,720-68,301,821 |
POLD1 | polymerase (DNA directed), delta 1, catalytic subunit |
5424 | P28340 | chr19: 50,384,204-50,418,018 |
POLD3 | polymerase (DNA-directed), delta 3, accessory subunit |
10714 | Q15054 | chr11: 74,493,851-74,669,117 |
POLD4 | polymerase (DNA-directed), delta 4, accessory subunit |
57804 | Q9HCU8 | chr11: 67,350,777-67,356,972 |
POLE | polymerase (DNA directed), epsilon, catalytic subunit |
5426 | Q07864 | chr12: 132,623,753-132,687,365 |
POLE2 | polymerase (DNA directed), epsilon 2, accessory subunit |
5427 | P56282 | chr14: 49,643,555-49,688,422 |
POLE3 | polymerase (DNA directed), epsilon 3, accessory subunit |
54107 | Q9NRF9 | chr9: 113,407,235-113,410,672 |
POLE4 | polymerase (DNA-directed), epsilon 4, accessory subunit |
56655 | Q9NR33 | chr2: 74,958,492-74,970,128 |
PPP3CA | protein phosphatase 3, catalytic subunit, alpha isozyme |
5530 | Q08209 | chr4: 101,023,409-101,348,278 |
PPP3R2 | protein phosphatase 3 regulatory subunit B, beta |
5535 | Q96LZ3 | chr9: 101,591,615-101,595,021 |
PRKACA | protein kinase, cAMP-dependent, alpha catalytic subunit |
5566 | P17612 | chr19: 14,091,688-14,118,084 |
PTTG1 | pituitary tumor-transforming 1 |
9232 | O95997 | chr5: 160,421,822-160,428,744 |
RANBP1 | RAN binding protein 1 |
5902 | P43487 | chr22: 20,115,938-20,127,357 |
RB1 | retinoblastoma 1 |
5925 | P06400 | chr13: 48,303,751-48,481,986 |
RELA | v-rel avian reticuloendotheliosis viral oncogene homolog A |
5970 | Q04206 | chr11: 65,653,596-65,663,094 |
RELB | v-rel avian reticuloendotheliosis viral oncogene homolog B |
5971 | Q01201 | chr19: 45,001,430-45,038,198 |
RRAS | related RAS viral (r-ras) oncogene homolog |
6237 | P10301 | chr19: 49,635,292-49,640,201 |
RRAS2 | related RAS viral (r-ras) oncogene homolog 2 |
22800 | P62070 | chr11: 14,277,926-14,364,506 |
SLC25A4 | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 |
291 | P12235 | chr4: 185,143,241-185,150,382 |
SLC25A5 | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 |
292 | P05141 | chrX: 119,468,400-119,471,319 |
SLC2A1 | solute carrier family 2 (facilitated glucose transporter), member 1 |
6513 | P11166 | chr1: 42,925,375-42,959,173 |
SMAD2 | SMAD family member 2 |
4087 | Q15796 | chr18: 47,808,957-47,931,146 |
SMAD3 | SMAD family member 3 |
4088 | P84022 | chr15: 67,063,763-67,195,195 |
SMAD4 | SMAD family member 4 |
4089 | Q13485 | chr18: 51,028,394-51,085,045 |
STAT5A | signal transducer and activator of transcription 5A |
6776 | P42229 | chr17: 42,287,547-42,311,943 |
STAT5B | signal transducer and activator of transcription 5B |
6777 | P51692 | chr17: 42,199,168-42,276,707 |
TCF3 | transcription factor 3 |
6929 | P15923 | chr19: 1,609,290-1,652,605 |
TGFB1 | transforming growth factor beta 1 |
7040 | P01137 | chr19: 41,301,587-41,353,911 |
TGFB2 | transforming growth factor beta 2 |
7042 | P61812 | chr1: 218,346,235-218,444,619 |
TGFBR1 | transforming growth factor beta receptor I |
7046 | P36897 | chr9: 99,104,038-99,154,192 |
TGFBR2 | transforming growth factor beta receptor II |
7048 | P37173 | chr3: 30,606,502-30,694,142 |
TLN1 | talin 1 |
7094 | Q9Y490 | chr9: 35,696,948-35,732,395 |
TNF | tumor necrosis factor |
7124 | P01375 | chr6: 31,575,567-31,578,336 |
TP53 | tumor protein p53 |
7157 | P04637 | chr17: 7,661,779-7,687,550 |
TP53INP1 | tumor protein p53 inducible nuclear protein 1 |
94241 | Q96A56 | chr8: 94,925,972-94,949,411 |
TRRAP | transformation/transcription domain-associated protein |
8295 | Q9Y4A5 | chr7: 98,877,933-99,013,243 |
TSPO | translocator protein |
706 | P30536 | chr22: 43,151,514-43,163,242 |
VCAM1 | vascular cell adhesion molecule 1 |
7412 | P19320 | chr1: 100,719,742-100,739,045 |
VDAC2 | voltage-dependent anion channel 2 |
7417 | P45880 | chr10: 75,210,154-75,231,448 |
VDAC3 | voltage-dependent anion channel 3 |
7419 | Q9Y277 | chr8: 42,391,624-42,405,897 |
WNT2 | wingless-type MMTV integration site family member 2 |
7472 | P09544 | chr7: 117,276,631-117,323,289 |
WNT2B | wingless-type MMTV integration site family member 2B |
7482 | Q93097 | chr1: 112,466,541-112,530,165 |
WNT3 | wingless-type MMTV integration site family member 3 |
7473 | P56703 | chr17: 46,762,506-46,833,154 |
WNT5A | wingless-type MMTV integration site family member 5A |
7474 | P41221 | chr3: 55,465,715-55,490,539 |
WNT5B | wingless-type MMTV integration site family member 5B |
81029 | Q9H1J7 | chr12: 1,529,891-1,647,243 |
WNT6 | wingless-type MMTV integration site family member 6 |
7475 | Q9Y6F9 | chr2: 218,859,821-218,874,233 |
XBP1 | X-box binding protein 1 |
7494 | P17861 | chr22: 28,794,555-28,800,597 |
XIAP | X-linked inhibitor of apoptosis |
331 | P98170 | chrX: 123,859,724-123,913,979 |
XPO1 | exportin 1 |
7514 | O14980 | chr2: 61,477,849-61,538,626 |
ZFP36 | ZFP36 ring finger protein |
7538 | P26651 | chr19: 39,406,813-39,409,412 |